FDA approves gene therapy for MPS IIIA - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA approves gene therapy for MPS IIIA

The one-time intravenous treatment uses adeno-associated virus serotype 9 to deliver a functional copy of the SGSH gene.

  • By

  • Kathryn Wighton

  • September 18, 2026

  • 2 min

Share

Original Source(s)

FDA approves gene therapy for MPS IIIA

  • by Kathryn Wighton

  • September 18, 2026

Related Content

Nirsevimab may curb RSV severity

Real-world estimates showed protection across emergency, inpatient, and intensive care settings during Canada’s first universal immunization season.

Error in Figure

  • September 14, 2026

FDA approves first therapy for Alexander disease

The antisense oligonucleotide reduces production of the abnormal protein that accumulates in supportive cells in the brain.